Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.
13h
Inquirer on MSNPH harm reduction advocates welcome US FDA marketing authorizations for ZYNLocal proponents of tobacco harm reduction have welcomed the recent U.S. Food and Drug Administration’s (FDA) marketing ...
Philip Morris' impressive Q3 results highlight robust performance in both core and reduced-risk products. Read why I remain ...
Denver City Council’s crusade against flavored nicotine products continues to vex those of us who, as a matter of civic ...
Philip Morris International Inc.’s stock touched an record high on Thursday after it issued a profit outlook that topped Wall ...
Smoke-free products accounted for 40% of total net revenues, tobacco company Philip Morris International (PMI) said in ...
Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...
Philip Morris International Shares Surge as Transformation Continues. Is It Too Late to Buy the Stock?
Trump administration withdraws FDA plan to ban menthol cigarettes ... billion Pernod Ricard will suffer too. Tobacco giant Philip Morris International's subsidiary Swedish Match North America ...
Jacek Olczak; Chief Executive Officer, Director; Philip Morris International Inc Emmanuel Babeau; Chief Financial Officer; Philip Morris International Inc Matthew Smith; Analyst; Stifel, Nicolaus & Co ...
Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of a presentation by Jacek Olczak, Chief ...
Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results